Paige M. Bracci, PhD, MPH

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Paige M. Bracci, PhD, MPH

Assistant Professor, Department of Epidemiology and Biostatistics, UCSF

paige.bracci@ucsf.edu

Phone: (415) 476-3354
Box 1228, UCSF
San Francisco, CA 94143-0808

View on UCSF Profiles

Cancer Center Membership

Program Member » Hematopoietic Malignancies» Cancer Genetics

Education

University of Vermont, Burlington, B.A., 1979-1983, Mathematics and Zoology
Boston University, Boston, M.P.H., 1985-1987, Epidemiology and Biostatistics
University of Toronto, Toronto, M.S., 1989-1991, Biostatistics
University of California, Berkeley, Ph.D., 2004-2007, Epidemiology


Professional Experience

  • 1984-1987
    Boston University School of Medicine, Boston, MA; Research Tech., Neuroanatomy
  • 1987-1988
    Boston Dept of Health and Hospitals, Boston, MA; Data Analyst, AIDS Epidemiology
  • 1988-1989
    State Laboratory Institute, Boston, MA; Laboratory Study Manager, AIDS
  • 1989
    University of Toronto, Toronto, ON, Canada; Teaching Assistant, Biostatistics
  • 1989-1991
    University of Toronto, Toronto, ON, Canada; Statistical consultant, Nutrition
  • 1992
    Health Outcomes Group, Palo Alto, CA; Statistical consultant
  • 1992-1995
    Stanford University Stroke Center, Stanford, CA; Scientific Programmer Analyst, Neurology
  • 1995-2000
    University of California San Francisco, San Francisco, CA; Sr. Statistician, Cancer Epidemiology
  • 2000-2008
    University of California San Francisco, San Francisco, CA; Specialist, Cancer Epidemiology
  • 2008-present
    University of California San Francisco, San Francisco, CA; Asst. Prof., Cancer Epidemiology
  • 2009-present
    University of California San Francisco; Joan Rombauer Endowed Fellowship

Honors & Awards

  • 2010
    Lymphoma Foundation of America Young Scientist Award

Selected Publications

  1. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas. 2016 Feb; 45(2):311-6.
    View on PubMed
  2. Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun. 2015; 6:10203.
    View on PubMed
  3. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. 2015 Dec 4.
    View on PubMed
  4. Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Ann Oncol. 2016 Jan; 27(1):208.
    View on PubMed
  5. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12).
    View on PubMed
  6. Cigarette smoking and risk of pancreatic cancer: a clinic-based case-control study in the San Francisco Bay Area. Ann Epidemiol. 2015 Nov; 25(11):816-23.
    View on PubMed
  7. Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun. 2015; 6:7539.
    View on PubMed
  8. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet. 2015 Aug; 47(8):911-6.
    View on PubMed
  9. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer. 2015 Nov 1; 137(9):2175-83.
    View on PubMed
  10. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015 Jun 25; 372(26):2499-508.
    View on PubMed
  11. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. PLoS One. 2015; 10(6):e0129983.
    View on PubMed
  12. Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Ann Oncol. 2015 Aug; 26(8):1776-83.
    View on PubMed
  13. Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1061-70.
    View on PubMed
  14. Vitamin d metabolic pathway genes and pancreatic cancer risk. PLoS One. 2015; 10(3):e0117574.
    View on PubMed
  15. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 5; 96(3):487-97.
    View on PubMed
  16. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiol Biomarkers Prev. 2015 May; 24(5):817-24.
    View on PubMed
  17. Associations of Non-Hodgkin Lymphoma (NHL) Risk With Autoimmune Conditions According to Putative NHL Loci. Am J Epidemiol. 2015 Mar 15; 181(6):406-21.
    View on PubMed
  18. Statin use and risk of pancreatic cancer: Results from a large, clinic-based case-control study. Cancer. 2015 Apr 15; 121(8):1287-94.
    View on PubMed
  19. Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. Int J Cancer. 2015 Aug 15; 137(4):826-36.
    View on PubMed
  20. A genome-wide association study of marginal zone lymphoma shows association to the HLA region. Nat Commun. 2015; 6:5751.
    View on PubMed

Go to UCSF Profiles, powered by CTSI